Isoproterenol (Isuprel, Medihaler-Iso)

Category:

  • Respiratory

Description:

  • Antiasthmatic, bronchodilator, vasopressor, sympathomimetic

Indications:

  • Mild or transient episodes of heart block and Stokes-Adams attacks (except when caused by ventricular tachycardia or fibrillation)

  • Cardiac arrest (until electric shock or pacemaker is available)

  • Bronchospasm occurring during anesthesia, asthma, chronic bronchitis, or emphysema

  • Hypovolemic and septic shock, low cardiac output states, CHF, cardiogenic shock

Contraindications:

  • Tachydysrhythmias, tachycardia or heart block caused by digitalis intoxication

  • Ventricular dysrhythmias requiring inotropic therapy, angina pectoris

Precautions:

  • Pregnancy category C

  • Hypovolemia, coronary artery disease, coronary insufficiency

  • Diabetes, hyperthyroidism

Adverse Reactions (Side Effects):

  • CNS: anxiety, dizziness, headache, mild tremors, nervousness, weakness

  • CV: angina, hypertension, hypotension, palpitations, tachycardia, tachydysrhythmias, ventricular dysrhythmias

  • GI: nausea, vomiting

  • RESP: pulmonary edema

  • SKIN: flushing of skin, sweating

Dosage:

Administered orally (inhalation via solution and aerosol), intravenously, intramuscularly, subcutaneously

  • Adult:            

    • Bronchospasm: 

      • MDI 1-2 puffs 4-6 times daily

      • NEB 0.25-0.5ml of a 1% solution diluted in 2-3ml normal saline or 0.25% and 0.5% undiluted, treatment may be repeated up to 5 times daily

    • Dysrhythmia/heart block: 

      • IV 0.02-0.06mg (1-3ml of 1:50,000 dilution) bolus, followed by subsequent doses of 0.01-0.2mg (0.5-10ml op 1:50,000 dilution)

      • IV INF 5 mcg/min initially, titrate to desired response, usual range 2-20 mcg/min

      • IM 0.2mg (1ml of 1:5,000 dilution) initially, subsequent doses of 0.02-1mg (0.1-5ml of 1:5,000 dilution)

      • SC 0.2mg (1ml of 1:5,000 dilution) initially, subsequent doses of 0.15-0.2mg (0.75-1ml of 1:5,000 dilution)

      • IC 0.02mg (0.1ml of 1:5,000 dilution)

    • Shock: 

      • IV INF 0.5-5 mcg/min (0.25-2.5ml of 1:500,000 dilution), titrate to patient response

  • Child:            

    • Bronchospasm: 

      • MDI 1-2 puffs up to 6 times daily; NEB 0.01 ml/kg of 1% solution; minimum dose 0.1 ml, max dose 0.5ml diluted in 2-3ml normal saline

    • Shock: 

      • IV INF 0.05-2 mcg/kg/min, rate (ml/hr) = dose (mcg/kg/min) X weight (kg) X 60 min/hr divided by concetration (mcg/ml)

 

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site